APREA THERAPEUTICS INC's ticker is APRE and the CUSIP is 03836J102. A total of 29 filers reported holding APREA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $9,503 | -50.0% | 28,710 | 0.0% | 0.00% | – |
Q3 2022 | $19,000 | -13.6% | 28,710 | 0.0% | 0.00% | – |
Q2 2022 | $22,000 | -59.3% | 28,710 | -1.7% | 0.00% | – |
Q1 2022 | $54,000 | -46.0% | 29,205 | -16.4% | 0.00% | – |
Q4 2021 | $100,000 | -44.8% | 34,952 | -1.3% | 0.00% | – |
Q3 2021 | $181,000 | +13.8% | 35,408 | +8.8% | 0.00% | – |
Q2 2021 | $159,000 | -70.5% | 32,530 | -69.2% | 0.00% | – |
Q1 2021 | $539,000 | -3.6% | 105,719 | -6.8% | 0.00% | – |
Q4 2020 | $559,000 | -80.3% | 113,424 | -3.9% | 0.00% | -100.0% |
Q3 2020 | $2,839,000 | -34.0% | 118,015 | +6.4% | 0.00% | 0.0% |
Q2 2020 | $4,299,000 | +52.3% | 110,865 | +36.6% | 0.00% | 0.0% |
Q1 2020 | $2,822,000 | -22.6% | 81,185 | +2.2% | 0.00% | 0.0% |
Q4 2019 | $3,644,000 | – | 79,406 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 1,259,662 | $6,437,000 | 2.66% |
COASTAL INVESTMENT MANAGEMENT, L.P. | 41,965 | $214,000 | 0.30% |
Redmile Group, LLC | 694,918 | $3,551,000 | 0.06% |
Quantamental Technologies LLC | 13,752 | $70,000 | 0.05% |
KENNEDY CAPITAL MANAGEMENT LLC | 342,486 | $1,750,000 | 0.04% |
PDT Partners, LLC | 87,734 | $448,000 | 0.03% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 75,000 | $383,000 | 0.01% |
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 49,100 | $251,000 | 0.01% |
NEXT Financial Group, Inc | 11,347 | $58,000 | 0.01% |
Sugarloaf Wealth Management, LLC | 1,500 | $8,000 | 0.00% |